{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:44:45Z","timestamp":1777059885356,"version":"3.51.4"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:p>Background. A National Institute of Child Health and Human Development Neonatal Research Network randomized trial showed that vitamin A supplementation reduced bronchopulmonary dysplasia (O2 at 36 weeks' postmenstrual age) or death in extremely low birth weight (ELBW) neonates (relative risk [RR]: 0.89). As with postnatal steroids or other interventions, it is important to ensure that there are no longer-term adverse effects that outweigh neonatal benefits.<\/jats:p>\n               <jats:p>Primary Objective. To determine if vitamin A supplementation in ELBW infants during the first month after birth affects survival without neurodevelopmental impairment at a corrected age of 18 to 22 months.<\/jats:p>\n               <jats:p>Design\/Methods. Infants enrolled in the National Institute of Child Health and Human Development vitamin A trial were evaluated at 18 to 22 months by carefully standardized assessments: Bayley Mental Index (MDI) and Psychomotor Index (PDI), visual and hearing screens, and physical examination for cerebral palsy (CP). The medical history was also obtained. Neurodevelopmental impairment (NDI) was predefined as \u22651 of MDI &amp;lt;70, PDI &amp;lt;70, CP, blind in both eyes, or hearing aids in both ears.<\/jats:p>\n               <jats:p>Results. Of 807 enrolled infants, 133 died before and 16 died after discharge. Five hundred seventy-nine (88%) of the 658 remaining infants were followed up. The primary outcome of NDI or death could be determined for 687 of 807 randomized infants (85%). Baseline characteristics and predischarge and postdischarge mortality were comparable in both study groups. NDI or death by 18 to 22 months occurred in 190 of 345 (55%) infants in the vitamin A group and in 204 of 342 (60%) of the control group (RR: 0.94; 95% confidence interval: 0.80-1.07). RRs for low MDI, low PDI, and CP were also &amp;lt;1.0. We found no evidence that neonatal vitamin A supplementation reduces hospitalizations or pulmonary problems after discharge.<\/jats:p>\n               <jats:p>Conclusion. Vitamin A supplementation for ELBW infants reduces bronchopulmonary dysplasia without increasing mortality or neurodevelopmental impairment at 18 to 22 months. However, this study was not powered to evaluate small magnitudes of change in long-term outcomes.<\/jats:p>","DOI":"10.1542\/peds.2004-1812","type":"journal-article","created":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T01:31:11Z","timestamp":1108517471000},"page":"e249-e254","source":"Crossref","is-referenced-by-count":119,"title":["Vitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months"],"prefix":"10.1542","volume":"115","author":[{"given":"Namasivayam","family":"Ambalavanan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Alabama, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon E.","family":"Tyson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical School, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical School, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nellie I.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Research Triangle Institute, Research Triangle Park, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty R.","family":"Vohr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women and Infants Hospital, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda L.","family":"Wright","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development Neonatal Research Network, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alabama, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,3,1]]},"reference":[{"key":"2021121011185205400_R1","doi-asserted-by":"crossref","unstructured":"Shenai JP, Chytil F, Jhaveri A, Stahlman MT. Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr.\u20081981;99:302\u2013305","DOI":"10.1016\/S0022-3476(81)80484-2"},{"key":"2021121011185205400_R2","doi-asserted-by":"crossref","unstructured":"Shenai JP, Chytil F, Stahlman MT. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res.\u20081985;19:185\u2013188","DOI":"10.1203\/00006450-198502000-00007"},{"key":"2021121011185205400_R3","doi-asserted-by":"crossref","unstructured":"Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr.\u20081987;111:269\u2013277","DOI":"10.1016\/S0022-3476(87)80086-0"},{"key":"2021121011185205400_R4","doi-asserted-by":"crossref","unstructured":"Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med.\u20081999;340:1962\u20131968","DOI":"10.1056\/NEJM199906243402505"},{"key":"2021121011185205400_R5","doi-asserted-by":"crossref","unstructured":"Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev.\u20082002;(4):CD000501","DOI":"10.1002\/14651858.CD000501"},{"key":"2021121011185205400_R6","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (&lt;96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001146","DOI":"10.1002\/14651858.CD001146"},{"key":"2021121011185205400_R7","doi-asserted-by":"crossref","unstructured":"Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics.\u20082004;113:394\u2013396","DOI":"10.1542\/peds.113.2.394"},{"key":"2021121011185205400_R8","doi-asserted-by":"crossref","unstructured":"Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993\u20131994. Pediatrics.\u20082000;105:1216\u20131226","DOI":"10.1542\/peds.105.6.1216"},{"key":"2021121011185205400_R9","unstructured":"Amiel-Tison C. Neuromotor status. In: Taeusch HW, Yogman MW, eds. Follow-up Management of the High-Risk Infant. Boston, MA: Little Brown and Company; 1987:115\u2013126"},{"key":"2021121011185205400_R10","unstructured":"Bayley N. Bayley Scales of Infant Development-II. San Antonio, TX: Psychological Corporation; 1993"},{"key":"2021121011185205400_R11","doi-asserted-by":"crossref","unstructured":"Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA.\u20081998;280:1690\u20131691","DOI":"10.1001\/jama.280.19.1690"},{"key":"2021121011185205400_R12","doi-asserted-by":"crossref","unstructured":"Sharek PJ, Baker R, Litman F, et al. Evaluation and development of potentially better practices to prevent chronic lung disease and reduce lung injury in neonates. Pediatrics.\u20082003;111(4). Available at: www.pediatrics.org\/cgi\/content\/full\/111\/4\/e426","DOI":"10.1542\/peds.111.SE1.e426"},{"key":"2021121011185205400_R13","doi-asserted-by":"crossref","unstructured":"Brion LP, Primhak RA, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev.\u20082002;(1):CD001817","DOI":"10.1002\/14651858.CD001817"},{"key":"2021121011185205400_R14","doi-asserted-by":"crossref","unstructured":"Ng GY, da S, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082001;(3):CD003214","DOI":"10.1002\/14651858.CD003214"},{"key":"2021121011185205400_R15","doi-asserted-by":"crossref","unstructured":"Ambalavanan N, Whyte RK. Mismatch between evidence and practice: common therapies in search of evidence. Clin Perinatol.\u20082003;30:305\u2013331","DOI":"10.1016\/S0095-5108(03)00021-6"},{"key":"2021121011185205400_R16","doi-asserted-by":"crossref","unstructured":"Ambalavanan N, Kennedy K, Tyson J, Carlo WA. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence?J Pediatr.\u20082004;145:304\u2013307","DOI":"10.1016\/j.jpeds.2004.04.046"},{"key":"2021121011185205400_R17","unstructured":"Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev.\u20082000;(2):CD000065"},{"key":"2021121011185205400_R18","doi-asserted-by":"crossref","unstructured":"Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev.\u20082001;(2):CD000144","DOI":"10.1002\/14651858.CD000144"},{"key":"2021121011185205400_R19","doi-asserted-by":"crossref","unstructured":"Ambalavanan N, Wu TJ, Tyson JE, Kennedy KA, Roane C, Carlo WA. Comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr.\u20082003;142:656\u2013661","DOI":"10.1067\/mpd.2003.214"},{"key":"2021121011185205400_R20","doi-asserted-by":"crossref","unstructured":"Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA.\u20082003;289:1124\u20131129","DOI":"10.1001\/jama.289.9.1124"},{"key":"2021121011185205400_R21","doi-asserted-by":"crossref","unstructured":"Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992\u20131995. Arch Pediatr Adolesc Med.\u20082000;154:725\u2013731","DOI":"10.1001\/archpedi.154.7.725"},{"key":"2021121011185205400_R22","doi-asserted-by":"crossref","unstructured":"Wagner E, Luo T, Drager UC. Retinoic acid synthesis in the postnatal mouse brain marks distinct developmental stages and functional systems. Cereb Cortex.\u20082002;12:1244\u20131253","DOI":"10.1093\/cercor\/12.12.1244"},{"key":"2021121011185205400_R23","doi-asserted-by":"crossref","unstructured":"Zile MH. Function of vitamin A in vertebrate embryonic development. J Nutr.\u20082001;131:705\u2013708","DOI":"10.1093\/jn\/131.3.705"},{"key":"2021121011185205400_R24","doi-asserted-by":"crossref","unstructured":"Thompson Haskell G, Maynard TM, Shatzmiller RA, Lamantia AS. Retinoic acid signaling at sites of plasticity in the mature central nervous system. J Comp Neurol.\u20082002;452:228\u2013241","DOI":"10.1002\/cne.10369"},{"key":"2021121011185205400_R25","doi-asserted-by":"crossref","unstructured":"Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr.\u20082001;21:167\u2013192","DOI":"10.1146\/annurev.nutr.21.1.167"},{"key":"2021121011185205400_R26","doi-asserted-by":"crossref","unstructured":"Stephensen CB, Rasooly R, Jiang X, et al. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol.\u20082002;168:4495\u20134503","DOI":"10.4049\/jimmunol.168.9.4495"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/3\/e249\/1020244\/zpe0030500e249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/3\/e249\/1020244\/zpe0030500e249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:16:03Z","timestamp":1639181763000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/3\/e249\/67268\/Vitamin-A-Supplementation-for-Extremely-Low-Birth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,3,1]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1812","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}